Haemonetics Corporation (HAE)
Official siteHEALTHCARE • MEDICAL DEVICES • NYSE
Market Cap: $5.53B
Last updated: Nov 17, 2026 at 4:28 PM ET
Haemonetics Corporation (HAE) Stock Chart
Haemonetics (HAE) has a latest price of $120.97 on Nov 17, 2026, 8.4% below its 52-week high of $132.00. Its price rose 64.6% over the past 12 months. The month-end price rose 258.1% over the 10 years through Oct 2026, a compound annual rate of 13.6%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $133.53 in Aug 2019 and its lowest $33.41 in Oct 2016, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart HAE with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for HAE.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price rose 11.6%, and over 6 months it rose 112.8%. The month-end price rose 40.4% over the 3 years through Oct 2026, a compound annual rate of 12.0%.
| Period | Change |
|---|---|
| 1 month | +1.9% |
| 3 months | +11.6% |
| 6 months | +112.8% |
| 12 months | +64.6% |
| 12 months, with dividends | +64.6% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +40.4% | +12.0% |
| 5 years | +74.1% | +11.7% |
| 10 years | +258.1% | +13.6% |
Price by Year
Its best calendar year was 2018, when the price rose 72.3%, and its weakest was 2021, when it fell 55.3%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $119.65 | +49.3% |
| 2025 | $80.15 | +2.7% |
| 2024 | $78.08 | -8.7% |
| 2023 | $85.51 | +8.7% |
| 2022 | $78.65 | +48.3% |
| 2021 | $53.04 | -55.3% |
| 2020 | $118.75 | +3.4% |
| 2019 | $114.90 | +14.8% |
| 2018 | $100.05 | +72.3% |
| 2017 | $58.08 | +44.5% |
Trading Range
The price is 6.1% above its 50-day average of $114.04 and 47.9% above its 200-day average of $81.81.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $120.97 | |
| 52-week high | $132.00 | -8.4% |
| 52-week low | $51.00 | +137.2% |
| 50-day average | $114.04 | +6.1% |
| 200-day average | $81.81 | +47.9% |
Price Risk
Over 3 years, its largest fall from a peak was 51.0%.
| Measure | Value |
|---|---|
| 1-year beta | 0.27 |
| Largest fall, 1 year | -40.1% |
| Largest fall, 3 years | -51.0% |
Valuation
Haemonetics traded at 16.3x earnings at the end of 2025, against a 5-year median of 21.0x and a 10-year median of 26.6x.
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About HAE
What is HAE's 1-year price change?
Haemonetics's price rose 64.6% over the past 12 months. With dividends included, the 12-month total return was 64.6%.
What is HAE's 5-year price change?
Haemonetics's month-end price rose 74.1% over the 5 years through Oct 2026, a compound annual rate of 11.7%. These figures leave out dividends.
What is HAE's 52-week high and low?
Haemonetics's 52-week high is $132.00 and its 52-week low is $51.00. Its latest price of $120.97 on Nov 17, 2026 is 8.4% below the high.
What is HAE's beta?
Haemonetics's 1-year beta against the S&P 500 is 0.27, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 40.1%.
Is the HAE chart free?
Yes. Advanced Charting for HAE is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
HAE pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors, Government Contracts